CRISPR/Cas9-generated p47phox-deficient cell line for Chronic Granulomatous Disease gene therapy vector development
Crossref DOI link: https://doi.org/10.1038/srep44187
Published Online: 2017-03-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wrona, Dominik
Siler, Ulrich
Reichenbach, Janine
Text and Data Mining valid from 2017-03-13
Version of Record valid from 2017-03-13
Article History
Received: 26 October 2016
Accepted: 6 February 2017
First Online: 13 March 2017
Competing interests
: The authors declare no competing financial interests.